Literature DB >> 25920541

Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.

Abhishek Lenka1, Ketan Ramakant Jhunjhunwala1, Jitender Saini2, Pramod Kumar Pal3.   

Abstract

Patients with Parkinson's disease (PD) may develop various non-motor symptoms (NMS) during the course of the illness and psychosis is one of the common NMS of PD. Visual hallucinations (VH) are the most common manifestation of psychosis in PD. The exact pathogenesis of VH in patients with PD is not clearly understood. Presence of VH has been described to be associated with rapid cognitive decline and increased nursing home placements in PD patients. A large number of structural and functional neuroimaging studies have been conducted to understand the cerebral basis of VH in PD. Structural imaging studies (Voxel Based Morphometry) have reported grey matter atrophy in multiple regions of the brain such as primary visual cortex, visual association cortex, limbic regions, cholinergic structures such as pedunculopontine nucleus and substantia innominata, which conclude possible alterations of brain regions associated with functions such as visuospatial-perception, attention control and memory. Most functional neuroimaging studies (functional MRI, positron emission tomography and single photon emission computerized tomography) have reported altered activation, blood flow, or reduced metabolism in both dorsal and ventral visual pathways, which probably indicates an alteration in the normal bottom-top visual processing and the presence of an aberrant top-down visual processing. This review critically analyzes the published studies on the structural and functional neuroimaging in PD patients with VH.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PET; Parkinson's disease; SPECT; VBM; Visual hallucinations; fMRI

Mesh:

Year:  2015        PMID: 25920541     DOI: 10.1016/j.parkreldis.2015.04.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

Review 2.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 3.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

Review 4.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

5.  Associative hallucinations result from stimulating left ventromedial temporal cortex.

Authors:  Elissa M Aminoff; Yuanning Li; John A Pyles; Michael J Ward; R Mark Richardson; Avniel S Ghuman
Journal:  Cortex       Date:  2016-07-26       Impact factor: 4.027

6.  Demonstration of Early Cognitive Impairment in Parkinson's Disease with Visual P300 Responses.

Authors:  Gülin Özmüş; Deniz Yerlikaya; Arife Gökçeoğlu; Derya Durusu Emek Savaş; Raif Çakmur; Beril Dönmez Çolakoğlu; Görsev G Yener
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

Review 7.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

8.  Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.

Authors:  Dominic H Ffytche; Joana B Pereira; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04       Impact factor: 10.154

Review 9.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

10.  Face pareidolia is associated with right striatal dysfunction in drug-naïve patients with Parkinson's disease.

Authors:  Hidetomo Murakami; Tomotaka Shiraishi; Tadashi Umehara; Shusaku Omoto; Maki Takahashi; Haruhiko Motegi; Takahiro Maku; Takeo Sato; Hiroki Takatsu; Teppei Komatsu; Keiko Bono; Kenichiro Sakai; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Sci       Date:  2021-04-22       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.